share_log

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence

SAB Biotherapeutics | 4:持股變動聲明-高管 Bausch Christoph Lawrence
SEC announcement ·  02/23 22:16
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息